The Hepatic Stellate Cells (HSCs) and Adipose Derived Stem Progenitor Cells (ASCs): are they Critical Multitargeted Endogenous Metabolic Modulators in syndrome X and EMS? Letter to Editor.
Krzysztof Marycz
Author Information
Krzysztof Marycz: Department of Experimental Biology, Faculty of Biology and Animal Science, Wrocław University of Environmental and Life Sciences, Norwida 27B, 50-375, Wrocław, Poland. krzysztof.marycz@upwr.edu.pl. ORCID
Bourebaba, L., Łyczko, J., Alicka, M., Bourebaba, N., Szumny, A., Fal, A. M., & Marycz, K. (2020). Inhibition of Protein-Tyrosine Phosphatase PTP1B and LMPTP Promotes Palmitate/Oleate-Challenged HepG2 Cell Survival by Reducing Lipoapoptosis, Improving Mitochondrial Dynamics and Mitigating Oxidative and Endoplasmic Reticulum Stress. Journal of Clinical Medicine, 9(5), 1294. https://doi.org/10.3390/jcm9051294 .
[DOI: 10.3390/jcm9051294]
Marycz, K., Szłapka-Kosarzewska, J., Geburek, F., & Kornicka-Garbowska, K. (2019). Systemic Administration of Rejuvenated Adipose-Derived Mesenchymal Stem Cells Improves Liver Metabolism in Equine Metabolic Syndrome (EMS)- New Approach in Veterinary Regenerative Medicine. Stem Cell Reviews and Reports, 15(6), 842–850. https://doi.org/10.1007/s12015-019-09913-3 .
[DOI: 10.1007/s12015-019-09913-3]
Bourebaba, L., Kornicka-Garbowska, K., Al Naem, M., Röcken, M., Łyczko, J., & Marycz, K. (2021). MSI-1436 improves EMS adipose derived progenitor stem cells in the course of adipogenic differentiation through modulation of ER stress, apoptosis, and oxidative stress. Stem Cell Research & Therapy, 12(1), 97. https://doi.org/10.1186/s13287-020-02102-x .
[DOI: 10.1186/s13287-020-02102-x]
Bourebaba, N., & Marycz, K. (2021). Hepatic stellate cells role in the course of metabolic disorders development – A molecular overview. Pharmacological Research, 170, 105739. https://doi.org/10.1016/j.phrs.2021.105739 .
[DOI: 10.1016/j.phrs.2021.105739]
Al Naem, M., Bourebaba, L., Kucharczyk, K., Röcken, M., & Marycz, K. (2020). Therapeutic mesenchymal stromal stem cells: Isolation, characterization and role in equine regenerative medicine and metabolic disorders. Stem Cell Reviews and Reports, 16(2), 301–322. https://doi.org/10.1007/s12015-019-09932-0 .
[DOI: 10.1007/s12015-019-09932-0]
Alicka, M., Kornicka-Garbowska, K., Roecken, M., & Marycz, K. (2019). Inhibition of the Low Molecular Weight Protein Tyrosine Phosphatase (LMPTP) as a Potential Therapeutic Strategy for Hepatic Progenitor Cells Lipotoxicity—Short Communication. International Journal of Molecular Sciences, 20(23), 5873. https://doi.org/10.3390/ijms20235873 .
[DOI: 10.3390/ijms20235873]
Herhaus, L., Al-Salihi, M., Macartney, T., Weidlich, S., & Sapkota, G. P. (2013). OTUB1 enhances TGFβ signalling by inhibiting the ubiquitylation and degradation of active SMAD2/3. Nature Communications, 4(1), 2519. https://doi.org/10.1038/ncomms3519 .
[DOI: 10.1038/ncomms3519]
